Ho Chi Minh City University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam.
Laboratory Department, Ho Chi Minh City University of Medicine and Pharmacy, Ho Chi Minh City University Medical Center, Ho Chi Minh City, Vietnam.
J Clin Pathol. 2023 May;76(5):339-344. doi: 10.1136/jclinpath-2021-207703. Epub 2021 Nov 29.
The aim of this study was to determine common variants in , including intron 22 inversion (Inv22), intron 1 inversion (Inv1) and point mutations, the transmission of these variants between patients with haemophilia A (HA) and their family members.
Genetic analysis was conducted in 71 patients who were clinically diagnosed with HA and 152 related female members in South Vietnam by a combination of inversion PCR (I-PCR), multiplex PCR and direct sequencing.
Variants in , including Inv22, point mutations (with 37 genotypes) and two novel variants, occupied 60 patients with HA. Among severe patients, the rate of Inv22 was 44%. Missense was the common point mutation of over 50% in patients with moderate HA and mild HA. Inv1 was absent in all patients. variants were also found in 119 female carriers (FCs) (78.3%) from families related to patients with HA. There were 56 mothers (93.3%) carrying variants and passing the same variants to their sons.
These findings were the first to provide important information about the presence of Inv22 and point mutation in Vietnamese patients with HA, the mothers and their female family members. It demonstrated that genetic diagnosis and counselling for HA carriers were essential factors for future improvements in comprehensive and equitable healthcare polices for patients with HA and FCs in Vietnam.
本研究旨在确定 中的常见变异,包括内含子 22 倒位(Inv22)、内含子 1 倒位(Inv1)和点突变,并研究这些变异在血友病 A(HA)患者及其家庭成员之间的传递情况。
在越南南部,通过反转录 PCR(I-PCR)、多重 PCR 和直接测序相结合的方法,对 71 例临床诊断为 HA 的患者和 152 名相关女性成员进行了基因分析。
包括 Inv22、点突变(37 种基因型)和两种新变异在内的 变异在 60 例 HA 患者中存在。在重度患者中,Inv22 的发生率为 44%。中度和轻度 HA 患者中超过 50%的错义点突变是常见的。所有患者均未发现 Inv1。在与 HA 患者相关的 119 名女性携带者(FCs)(78.3%)中也发现了 变异。56 名母亲(93.3%)携带 变异,并将相同的变异传递给儿子。
这些发现首次提供了有关越南 HA 患者、母亲及其女性家庭成员中存在 Inv22 和点突变的重要信息。它表明,对 HA 携带者进行遗传诊断和咨询是未来提高越南 HA 患者和 FCs 全面、公平医疗保健政策的重要因素。